Karamitopoulou, E <br/><br/>
Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas.  [electronic resource] 

 -  Human pathology  Feb 1998 
 - 140-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0046-8177 
<br/><br/><label>Standard No.: </label>10.1016/s0046-8177(98)90224-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Nuclear<br/>Apoptosis<br/>Biomarkers, Tumor--metabolism<br/>Cell Division<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Ki-67 Antigen--metabolism<br/>Male<br/>Meningeal Neoplasms--metabolism<br/>Meningioma--metabolism<br/>Middle Aged<br/>Nuclear Proteins--metabolism<br/>Prognosis<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Retrospective Studies<br/>Tumor Suppressor Protein p53--metabolism